InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-26 · accession 0001225208-24-003093 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-02-27 2024-02-26 BSX Butcher Arthur C EVP, Grp Pres, MedSurg, APAC M - OptEx $21.40 +4,185 37.3K +13% +$89.5K
D 2024-02-27 2024-02-26 BSX Butcher Arthur C EVP, Grp Pres, MedSurg, APAC S - Sale+OE $67.07 -9,335 28.9K -24% -$626.1K
DM 2024-02-27 2024-02-26 BSX Butcher Arthur C EVP, Grp Pres, MedSurg, APAC M - OptEx $0.00 -4,185 22.2K -16% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-26 M A 1,009 $17.26 38,272 D — —
2 Common Common Stock 2024-02-26 S D 9,335 $67.07 28,937 D — —
3 Common Common Stock 2024-02-26 M A 3,176 $22.71 37,263 D — —
4 Derivative Stock Option (Right to Buy) 2024-02-26 M D 1,009 $0.00 7,063 D $17.26 · — to 2026-02-22 1,009 Common Stock (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
5 Derivative Stock Option (Right to Buy) 2024-02-26 M D 3,176 $0.00 22,236 D $22.71 · — to 2026-06-01 3,176 Common Stock (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on June 1, 2017, the first anniversary of the date of grant.